Dangerous Drugs Side Effects
Everyone knows that when you are prescribed medication it can have side effects. In most cases the side effects are just a minor inconvenience, however in some cases the side effects can be very serious. The Federal Drug Administration (FDA) will at times issue heightened warnings about some medications that have been approved for use for years. Our dangerous drug lawyers have handled hundreds of cases where the side effects have been serious.
If you or a loved one were prescribed any these potentially dangerous drugs and suffered from complications you need to contact our dangerous drug attorneys today.
- Avandia (generic name rosiglitazone)
- Meridia (generic name sibutramine)
- Sudafed (generic phenylephrine)
- Low Testosterone Thearpy
If you or your loved one were prescribed the diabetes drug Avandia, also known by the generic name of Rosiglitazone, it is important to know that this drug has been linked with serious cardiovascular problems. Warnings have been raised that Avandia can cause heart attacks and strokes. Cardiovascular problems caused by Avandia may entitle you to compensation. Contact one of our Avandia Lawyers now for a free consultation.
What is Avandia and What Condition Does It Treat?
Avandia, also known as Rosiglitazone, is a drug used for treatment of diabetes, has been linked to serious cardiovascular problems such as heart attacks and strokes and has caused the United States Food and Drug Administration (“FDA”) to severely limit access to this potentially dangerous drug.
What are the Potential Side Effects?
On September 23, 2010, the US Federal Drug Administration issued statement that it will “significantly restrict the use of the diabetes drug Avandia (rosiglitazone) to patients with Type 2 diabetes who cannot control their diabetes on other medications. These new restrictions are in response to data that suggest an elevated risk of cardiovascular events, such as heart attack and stroke, in patients treated with Avandia.”
Meridia and Potential Side Effects
Abbott Laboratories, the manufacturer of the diet drug Meridia (also known by the generic name of sibutramine) has announced the voluntary withdrawal of the product due to concerns over an increased risk of heart attack or stroke. Patients who have used Meridia and suffered a subsequent heart attack or stroke should seek the advice of a qualified and experienced dangerous drug lawyer to determine if they are entitled to compensation.
Abbott resorted to this measure after being requested to do so by the United States Food and Drug Administration (“FDA”). The FDA was prompted to take this drastic action after clinical trials demonstrated a link between the medication and the serious cardiovascular events.
“Physicians are advised to stop prescribing Meridia to their patients, and patients should stop taking this medication. Patients should talk to their health care provider about alternative weight loss and weight loss maintenance programs.”
Meridia was first approved as an obesity drug in 1997 for weight loss and maintenance of weight loss.
Pradaxa Side Effects
If you or a loved one took the medication Pradaxa (dabigatran etexilate mesylate) and suffered severe side effects such as internal bleeding or a heart attack, you should immediately seek the advice of an injury lawyer to determine if you are entitled to compensation.
What is Pradaxa and What Does It Treat?
Pradaxa is a blood thinner used to prevent blood clots and strokes. Pradaxa is used to lessen the risk of strokes in people with non-valvular atrial fibrillation (AF). The United States Food and Drug Administration (FDA) has published warnings showing that drugs like Pradaxa can cause internal bleeding and death. The FDA also states that patients with AF should not stop taking the medication without speaking with their doctor.
Was your baby born with a birth defect such as endocardial cushion defect after you took the decongestant Sudafed while pregnant? You should know that recent scientific studies confirm much greater increased risk of birth defects among women who used decongestants such as Sudafed while pregnant. These risks include endocardial cushion defects, pyloric stenosis, ear defects and esophageal defects.
The generic form of Sudafed is phenylephrine. If your baby was born with a birth defect after you used an over the counter decongestant such as Sudafed, you should seek the advice of a board certified personal injury attorney as soon as possible. You and your baby might be entitled to compensation.
Contact dangerous drug lawyer Michael P. Fleming now for a free case evaluation.
Testosterone Low-T Heart Attack and Stroke
Testosterone is a hormone that both men and women produce. In men, testosterone helps maintain muscle mass and strength, sex drive, sperm production, bone density, fat distribution, and red blood cell production. As men age their testosterone levels gradually decline. It is hypothesized that a man’s testosterone levels decrease at a rate of 1% annually after reaching the age of 30. In addition to the natural aging process, other causes of low testosterone levels include inflammatory diseases, alcoholism and cirrhosis of the liver, stress, obesity, and radiation or chemotherapy treatments for cancer. A blood test is the only way to detect testosterone levels.
FDA Warns of Potential Serious Side Effects
Since the media frenzy targeting middle-aged men and encouraging them to have their T levels checked in 2008, testosterone sales have risen more than 1,800%. In 2012, those sales exceeded $1.9 billion. In 2011, the number of prescriptions issued for low T treatments exceeded 5.3 million. Unfortunately, no one really knows if diagnosis and low T therapies really work. In fact, the FDA has recently released an alert regarding the risk of stroke, heart attack, or even death for men taking testosterone products.
This investigation by the FDA was prompted by two recent studies indicating an increased risk of “cardiovascular events” amongst men using testosterone replacement therapies. The studies appear to link increased cardiovascular problems such as heart attacks in both men over and under 65. In fact, the risk of heart attack doubled for men over 65 years of age within the 90 days after beginning “low T” therapy. Moreover, the risk of heart attacks tripled for men under 65 years old with a history of heart disease. Although the reason for this increase is unclear, researchers believe the increase risk could be due to testosterone promoting clotting of the blood. Nonetheless, the risks are real and potentially life-threatening.
The studies’ conclusions and FDA’s willingness to investigate their indications, provide good reason to worry about heart attacks of men taking low T therapies, especially those who are older, already in compromised health, or with existing heart issues. As the FDA continues its investigation, patients are cautioned not to discontinue use of any “low T” treatment until discussing the health risks with their medical provider.